Azeez, N., Attarbashee, R. (2026). Ameliorative Effect of Ezetimibe on Inflammatory and Apoptotic Biomarkers in Methotrexate-Induced Salivary Gland Injury. , 23(2), 53-58. doi: 10.33899/iraqij.p.2026.168717.1178
Nashwah Subhi Azeez; Rana Khairi Attarbashee. "Ameliorative Effect of Ezetimibe on Inflammatory and Apoptotic Biomarkers in Methotrexate-Induced Salivary Gland Injury". , 23, 2, 2026, 53-58. doi: 10.33899/iraqij.p.2026.168717.1178
Azeez, N., Attarbashee, R. (2026). 'Ameliorative Effect of Ezetimibe on Inflammatory and Apoptotic Biomarkers in Methotrexate-Induced Salivary Gland Injury', , 23(2), pp. 53-58. doi: 10.33899/iraqij.p.2026.168717.1178
Azeez, N., Attarbashee, R. Ameliorative Effect of Ezetimibe on Inflammatory and Apoptotic Biomarkers in Methotrexate-Induced Salivary Gland Injury. , 2026; 23(2): 53-58. doi: 10.33899/iraqij.p.2026.168717.1178

Ameliorative Effect of Ezetimibe on Inflammatory and Apoptotic Biomarkers in Methotrexate-Induced Salivary Gland Injury

Iraqi Journal of Pharmacy
Article 2, Volume 23, Issue 2, June 2026, Pages 53-58    PDF (728.39 K)
Document Type: Research Paper
DOI: 10.33899/iraqij.p.2026.168717.1178
Authors
Nashwah Subhi Azeez* 1; Rana Khairi Attarbashee2
1Department of Prosthetic Dentistry, College of Dentistry, University of Mosul, Mosul, Iraq
2Department of Dental Basic Sciences, College of Dentistry, University of Mosul, Mosul, Iraq
Abstract
Background: Methotrexate (MTX) is a chemotherapeutic agent used to treat various malignancies and autoinflammatory conditions. MTX have an adverse effect on oral tissues, particularly by compromising salivary gland (SG) function. Ezetimibe is a lipid-lowering medication that has more potent anti-inflammatory, and anti-apoptotic effects. Aims: This research aimed to assess the protective effects of ezetimibe on SG in rats subjected to MTX -induced alterations. Methods: A total of 18 male albino rats were haphazardly assigned into 3 groups. Group I (vehicle control) received normal saline solution for 10 days, while the group II was induced by MTX injection (20 mg/kg, single intraperitoneal, i.p.) on the sixth day of the experiment. Group III (Ezetimibe+ MTX) received oral Ezetimibe 10 mg/kg once daily for 10 days. SG tissues from rats were collected on day 11 and euthanized for biochemical and immunohistochemical (IHC) testing. Results: Ezetimibe significantly ameliorated the biochemical and IHC dysregulation caused by MTX, as evidenced by reduced levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and an elevation in B-cell lymphoma 2 (Bcl-2) level. Conclusions: Ezetimibe is an anti-inflammatory and antiapoptotic agent that may be a promising approach to reducing MTX toxicity in submandibular glandular tissue.
Keywords
Ezetimibe; Immunohistochemistry; Salivary gland
References
  1. Dinu CA, Stefan CS, Mihalache D, Carnaru MV, Rusu-Negraia M. The role of salivary glands in oral cavity homeostasis: secretion, composition and neuroendocrine control. Romanian Journal of Oral Rehabilitation 2025;17(1):897–909.
  2. Vistoso Monreal A, Polonsky G, Shiboski C, Sankar V, Villa A. Salivary gland dysfunction secondary to cancer treatment. Frontiers in Oral Health 2022;3:907778.
  3. Hamed KM, Dighriri IM, Baomar AF, Alharthy BT, Alenazi FE, Alali GH, et al. Overview of methotrexate toxicity: a comprehensive literature review. Cureus 2022;14(9):e29518.
  4. Attarbashee RK, Hamodat HF, Mammdoh JK, Ridha-Salman H. The Possible effect of Bosentan on the methotrexate-induced salivary gland changes in male rats: histological and Immunohistochemical study. Toxicology Research 2025;14(1):tfaf007.
  5. Aboulfotoh MM. Effect of cevimeline and different concentration of gum arabic on parotid salivary gland function in methotrexate-induced xerostomia: a comparative study. BMC Oral Health 2024;24(1):624.
  6. Attarbashee RK, Al-Athari AJH, Shihab EM, Ridha-Salman H, Zigam QA, Abbas WJ, et al. Suppressive effect of rutin on methotrexate-induced salivary gland injury in rats. Pharmakeftiki 2025;37(2S):187.
  7. Fattah HSA, Omar EM. The protective role of curcumin nanoparticles on the submandibular salivary gland toxicity induced by methotrexate in male rats. Archives of Oral Biology 2023;152:105717.
  8. Rajasekaran JJ, Krishnamurthy HK, Bosco J, Jayaraman V, Krishna K, Wang T, et al. Oral Microbiome: A Review of Its Impact on Oral and Systemic Health. Microorganisms 2024;12(9):1797.
  9. Kızıl HE, Caglayan C, Darendelioğlu E, Ayna A, Gür C, Kandemir FM, et al. Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2/HO-1 and Bax/Bcl2/Caspase-3 signaling pathways. Molecular Biology Reports 2023;50(4):3479-88.
  10. Ahmed AAM, Selim MAA, El-Sayed NM. α-Lipoic acid ameliorates oral mucositis and oxidative stress induced by methotrexate in rats. Histological and immunohistochemical study. Life Sciences 2017;171:51-9.
  11. Taha RM, Abdel-Latif GA, Said RH. The Prospective Effect of Green Tea versus Pomegranate Peels Extracts on Submandibular Salivary Glands of Albino Rats after Methotrexate Administration (Histological and Immunohistochemical Study). International Journal of Dentistry 2024;2024:3290187.
  12. Faggiotto A, Paoletti R. Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins? Current Atherosclerosis Reports 2000;2(1):20-5.
  13. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proceedings of the National Academy of sciences 2005;102(23):8132-7.
  14. Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. The New England Journal of Medicine 2015;372(25):2387-97.
  15. Tobaru T, Seki A, Asano R, Sumiyoshi T, Hagiwara N. Lipid-lowering and anti-inflammatory effect of ezetimibe in hyperlipidemic patients with coronary artery disease. Heart Vessels 2013;28(1):39-45.
  16. Mäki-Petäjä KM, Booth AD, Hall FC, Wallace SML, Brown J, McEniery CM, et al. Ezetimibe and Simvastatin Reduce Inflammation, Disease Activity, and Aortic Stiffness and Improve Endothelial Function in Rheumatoid Arthritis. Journal of the American College of Cardiology 2007;50(9):852-8.
  17. Mostafa RE, Abdel-Rahman RF. Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt/NF-κB/STAT3/CXCL10 signaling axis. Journal of Pharmacy and Pharmacology 2023;75(4):533-43.
  18. Seferos N, Christine T, Tsamouri M, Kotsiou A. Effects of simvastatin and ezetimibe on rats' parotid in experimental freund's adjuvant arthritis. International Journal of Health Sciences and Research 2017;7(06):167-72.
  19. Drishya S, Dhanisha SS, Guruvayoorappan C. Antioxidant-rich fraction of Amomum subulatum fruits mitigates experimental methotrexate-induced oxidative stress by regulating TNF-α, IL-1β, and IL-6 proinflammatory cytokines. Journal of Food Biochemistry 2022;46(4):e13855.
  20. Mammadov R, Suleyman B, Akturan S, Cimen FK, Kurt N, Suleyman Z, et al. Effect of lutein on methotrexate-induced oxidative lung damage in rats: a biochemical and histopathological assessment. Korean Journal of Internal Medicine 2019;34(6):1279-86.
  21. Dogra A, Gupta D, Bag S, Ahmed I, Bhatt S, Nehra E, et al. Glabridin ameliorates methotrexate-induced liver injury via attenuation of oxidative stress, inflammation, and apoptosis. Life Sciences 2021;278:119583.
  22. Yousef DM, Abd El-Fatah SS, Al-Semeh M, Amira E. Oxidative stress changes induced by methotrexate on parotid gland structure of adult male albino rat: can vitamin C ameliorate these changes? The Medical Journal of Cairo University 2019;87:2555-65.
  23. Fathi R, Abd Allah D, Helmy I. Effect of Green tea and black seed on methotrexate induced cytotoxicity of the oral mucosa, tongue and the submandibular salivary gland of Albino rats. Egyptian Dental Journal 2023;69(1):413-26.
  24. Ungureanu LB, Grădinaru I, Ghiciuc CM, Amălinei C, Gelețu GL, Petrovici CG, et al. Atrophy and inflammatory changes in salivary glands induced by oxidative stress after exposure to drugs and other chemical substances: a systematic review. Medicina 2023;59(9):1692.
  25. Qin L, Yang Y-B, Yang Y-X, Zhu N, Li S-X, Liao D-F, et al. Anti-inflammatory activity of ezetimibe by regulating NF-κB/MAPK pathway in THP-1 macrophages. Pharmacology 2014;93(1-2):69-75.
  26. Cho Y, Kim R-H, Park H, Wang HJ, Lee H, Kang ES. Effect of ezetimibe on glucose metabolism and inflammatory markers in adipose tissue. Biomedicines 2020;8(11):512.
  27. Tamaki N, Ueno H, Morinaga Y, Shiiya T, Nakazato M. Ezetimibe ameliorates atherosclerotic and inflammatory markers, atherogenic lipid profiles, insulin sensitivity, and liver dysfunction in Japanese patients with hypercholesterolemia. Journal of Atherosclerosis and Thrombosis 2012;19(6):532-8.
  28. Nam KT, Park JS, Kim SH, Lee M, Kim G, Min BS, et al. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radical Biology and Medicine 2016;99:520-32.
  29. Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution. Genes Cells 2011;16(2):123-40.
  30. Moon J, Lee S-Y, Na HS, Lee AR, Cho K-H, Choi JW, et al. Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation. Frontiers in Immunology 2022;13:13:922531.
  31. Jaafar F, Abu-Raghif A. Ezetimibe Ameliorates Clinical Parameters, Oxidative Stress, and Adhesion Molecules in Experimentally Induced Colitis in Male Rat Models. Opera Medica et Physiologica 2023;10(4):103-10.
  32. Jaafar FR, Abu-Raghif A. Comparative treatment of Sulfasalazine+ Ezetimibe combination and Sulfasalazine in a rat model with induced colitis. Journal of Medicine and Life 2023;16(8):1165.
  33. Jaafar FR, Abu-Raghif AR. The Effects of Sulfasalazine and Ezetimibe on Proinflammatory Cytokines in Male Rat with Induced Colitis: A Comparative Study. Medical Journal of Babylon 2024;21(3):681-5.
  34. Ribeiro DA, Salvadori DM, Marques ME. Abnormal expression of bcl‐2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4‐nitroquinoline 1‐oxide. International journal of experimental pathology 2005;86(6):375-82.
  35. Mansouri H, Mnango LF, Magorosa EP, Sauli E, Mpolya EA. Ki-67, p53 and BCL-2 Expressions and their Association with Clinical Histopathology of Breast Cancer among Women in Tanzania. Scientific Reports 2019;9(1):9918.
  36. de Mello Gomes Á N, Nagai MA, Lourenço SV, Coutinho-Camillo CM. Apoptosis and proliferation during human salivary gland development. Journal of Anatomy 2019;234(6):830-8.
  37. Larsen SR, Bjørndal K, Godballe C, Krogdahl A. Prognostic significance of Ki-67 in salivary gland carcinomas. Journal of oral pathology and medicine 2012;41(8):598-602.
  38. Hu S, Wang Y, Xu Z, Zhou Y, Cao J, Zhang H, et al. Identification of the Bcl-2 and Bax homologs from Rhipicephalus haemaphysaloides and their function in the degeneration of tick salivary glands. Parasit Vectors 2021;14(1):386.
  39. Ali N, Rashid S, Nafees S, Hasan SK, Sultana S. Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis. Molecular and Cellular Biochemistry 2014;385:215-23.
  40. Al–Moula AD, Al-Mashhadane FA, Mammdoh JaK. Effects of 6–Mercaptopurine on Salivary Glands in Rabbit. Al-Rafidain Dental Journal 2012;12(2):266-73.
  41. Kaplan HM, Pazarci P. Antiproliferative and Apoptotic Effects of Tempol, Methotrexate, and Their Combinations on the MCF7 Breast Cancer Cell Line. ACS Omega 2024;9(6):6658-62.
  42. Spurlock CF, 3rd, Aune ZT, Tossberg JT, Collins PL, Aune JP, Huston JW, 3rd, et al. Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. Arthritis Rheum 2011;63(9):2606-16.
  43. Freeman ML, Clagett BM, Moisi D, Yeh E, Morris CD, Ryu A, et al. Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV. Frontiers in Immunology 2022;13:924718.
  44. Melikova NI, Tashkenbaeva UA. Impact of combination therapy on Ki-67 and Bcl-2 expression in psoriasis. Russian Journal of Skin and Venereal Diseases 2023;26(4):375-82.
  45. Kızıl HE, Caglayan C, Darendelioğlu E, Ayna A, Gür C, Kandemir FM, et al. Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2/HO-1 and Bax/Bcl2/Caspase-3 signaling pathways. Molecular Biology Reports 2023;50(4):3479-88.
  46. Amarnani D, Machuca-Parra AI, Wong LL, Marko CK, Stefater JA, Stryjewski TP, et al. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy. Investigative Ophthalmology and Visual Science 2017;58(10):3940-9.
  47. Wu S, Shao M, Zhang Y, Shi D. Activation of RSK2 upregulates SOX8 to promote methotrexate resistance in gestational trophoblastic neoplasia. Laboratory Investigation 2021;101(11):1494-504.
  48. Qin J, Wang L-l, Liu Z-y, Zou Y-l, Fei Y-j, Liu Z-x. Ezetimibe protects endothelial cells against oxidative stress through Akt/GSK-3β pathway. Current Medical Science 2018;38(3):398-404.
  49. Fathy N, Farouk S, Sayed RH, Fahim AT. Ezetimibe ameliorates cisplatin‐induced nephrotoxicity: A novel therapeutic approach via modulating AMPK/Nrf2/TXNIP signaling. The Federation of American Societies for Experimental Biology Journal 2024;38(1):e23382.
  50. Xu Y, Bai L, Yang X, Huang J, Wang J, Wu X, et al. Recent advances in anti-inflammation via AMPK activation. Heliyon 2024;10(13).
Statistics
Article View: 212
PDF Download: 129


Journal Management System. Powered by iJournalPro.com